September 18, 2024

Surprising Findings With Nivolumab in Bladder Cancer Trials – Targeted Oncology

September 17, 2024

Combination Treatment Extends Survival in Advanced Bladder Cancer – Feinberg News Center

September 17, 2024

‘One of the Most Impactful’ ESMO Studies: Durvalumab in Muscle-Invasive Bladder Cancer – Medscape

September 16, 2024

SPHK1 promotes bladder cancer metastasis via PD-L2/c-Src/FAK signaling cascade | Cell Death & Disease – Nature.com

September 16, 2024

Neoadjuvant TAR-200/Cetrelimab Combo Shows Activity in Muscle-Invasive Bladder Cancer – OncLive